Gmo Emerging is trading at 22.35 as of the 17th of October 2025; that is 0.62 percent decrease since the beginning of the trading day. The fund's open price was 22.49. Gmo Emerging has less than a 13 % chance of experiencing some financial distress in the next two years of operation and had a strong performance during the last 90 days. The performance scores are derived for the period starting the 19th of July 2025 and ending today, the 17th of October 2025. Click here to learn more.
The fund invests primarily in debt of emerging country sovereign and quasi-sovereign issuers. Under normal circumstances, it invests directly and indirectly at least 80 percent of its assets in debt investments tied economically to emerging countries. More on Gmo Emerging Ntry
Gmo Emerging Ntry [GMCDX] is traded in USA and was established 17th of October 2025. Gmo Emerging is listed under GMO category by Fama And French industry classification. The fund is listed under Emerging Markets Bond category and is part of GMO family. This fund currently has accumulated 3.87 B in assets under management (AUM) with no minimum investment requirementsGmo Emerging Ntry is currently producing year-to-date (YTD) return of 10.34% with the current yeild of 0.23%, while the total return for the last 3 years was 15.45%.
Check Gmo Emerging Probability Of Bankruptcy
Gmo Emerging financial ratios help investors to determine whether Gmo Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Gmo with respect to the benefits of owning Gmo Emerging security.